Pharmaceutical compositions comprising 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzo- diazepine; or a pharmaceutically acceptable salt thereof. The compositions are used for treating, preventing or delaying the onset of disorders mediated by LTB.sub.4, TXA.sub.2 or adenosine.

 
Web www.patentalert.com

< Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation

< CGRP receptor antagonists

> Bicyclic derivatives as modulators of ion channels

> Activatable recombinant neurotoxins
~ 00621